SCHEMBL31721175

SCHEMBL31721175

Cn1ncc2ccc(C(=O)O)nc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.42
CCNC P24863 3/20 0.41
CDK8 P49336 3/20 0.41
KDM4E B2RXH2 8/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ACMSD Q8TDX5 1/20 0.41
ALDH1A1 P00352 3/20 0.40
POLB P06746 2/20 0.40
GAA P10253 1/20 0.40
APOBEC3A P31941 1/20 0.40
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
KMO O15229 1/20 0.38
MMP2 P08253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30341599 0.86 IRAK4 (0.43) CCNCCDK8MAPTKMORXFP1
SCHEMBL31721208 0.81 PDE1C (0.46) CCNCCDK8KDM4EALDH1A1GAA
SCHEMBL19465607 0.78 KDM4E (0.47) MGAMCCNCCDK8KDM4ETDP1
SCHEMBL31721248 0.78 CYP1A2 (0.53) KDM4ETSHRALDH1A1POLBGAA
SCHEMBL31749124 0.77 CDK8 (0.36) CCNCCDK8KDM4EALDH1A1GAA
SCHEMBL19465591 0.75 KDM4E (0.53) MGAMKDM4ETDP1ALOX15TSHR
SCHEMBL22453989 0.74 MGAM (0.44) MGAMCCNCCDK8KDM4ETDP1
SCHEMBL29549763 0.74 MGAM (0.44) MGAMCCNCCDK8KDM4ETDP1
SCHEMBL25382823 0.73 NOTUM (0.39) CDK8GAAMAPTRAB9AKMO
SCHEMBL14645392 0.73 MGAM (0.43) MGAMCCNCCDK8KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025231152-A1 COMPOUNDS AND METHODS FOR RESTORING BETA-ADRENERGIC RECEPTOR FUNCTION THE CLEVELAND CLINIC FOUNDATION (US) 2025-11-06 WO disclosed